Despite a wide array of evidence supporting a predominant role of cDC1s in anti-tumor immunity, CD1c+ CD14− cDC2s also participate by infiltrating tumors and triggering CD4+ T cell responses at tumor draining lymph nodes [102,138]. Here, CD14 is linked to neoplasm.